ACB
NASDAQ
CA
Aurora Cannabis Inc. - Common Shares
$3.44
▲ +$0.09
(+2.69%)
Vol 690K
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$327.2M
ROE
-10.6%
Margin
-16.0%
D/E
18.86
Beta
1.84
52W
$5–$10
Wall Street Consensus
10 analysts · Apr 20261
Strong Buy
5
Buy
4
Hold
0
Sell
0
Strong Sell
60.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 0.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.21 | $0.03 | $-0.18 |
| Sep 2025 | $0.05 | $-0.23 | $-0.28 |
| Jun 2025 | $0.23 | $-0.27 | $-0.50 |
| Mar 2025 | $0.13 | $-0.44 | $-0.57 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $88.2M | $90.5M | $98.0M | $90.4M | $94.2M |
| Net Income | — | $28.6M | -$24.6M | -$15.2M | -$51.5M | $1.8M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -3.5% | 0.4% | -3.5% | -3.5% | -10.6% | -10.6% |
| P/E (TTM) | — | 163.79 | — | — | — | — |
| Net Margin | -15.5% | 0.7% | -5.4% | -5.4% | -16.0% | -16.0% |
| Gross Margin | -0.7% | 3.6% | 4.0% | 4.0% | 1.7% | 1.7% |
| D/E Ratio | 18.41 | 18.44 | 18.41 | 18.41 | 18.86 | 18.86 |
| Current Ratio | 2.97 | 4.31 | 2.97 | 2.97 | 3.41 | 3.41 |
Key Ratios
ROA (TTM)
-7.1%
P/S (TTM)
0.89
P/B
0.6
EPS (TTM)
$-1.05
CF/Share
$-0.38
Rev Growth 3Y
+15.8%
52W High
$9.90
52W Low
$4.95
$4.95
52-Week Range
$9.90
Financial Health
Free Cash Flow
$11.0M
Net Debt
$44.6M
Cash
$56.4M
Total Debt
$101.0M
As of Dec 31, 2025
How does ACB compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
ACB valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
0.9
▼
82%
below
peers
(5.0)
vs Peers
vs Industry
Undervalued
P/B ratio
0.6
▼
71%
below
peers
(2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
ACB profitability vs Pharmaceuticals peers
ROE
-10.6%
▲
80%
above
peers
(-54.3%)
vs Peers
vs Industry
Top tier
Net margin
-16.0%
▲
66%
above
peers
(-47.4%)
vs Peers
vs Industry
Below avg
Gross margin
1.7%
▼
98%
below
peers
(68.3%)
vs Peers
vs Industry
Weak
ROA
-7.1%
▲
81%
above
peers
(-37.4%)
vs Peers
vs Industry
Top tier
ACB financial health vs Pharmaceuticals peers
D/E ratio
18.9
▲
1125%
above
peers
(1.5)
vs Peers
vs Industry
Above avg
Current ratio
3.4
▲
2%
above
peers
(3.4)
vs Peers
vs Industry
In line
Beta
1.8
▲
95%
above
peers
(0.9)
vs Peers
vs Industry
More volatile
ACB fundamentals radar
ACB
Peer median
Industry
ACB profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio